Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cardiovascular effects of fingolimod: A review article.
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.
Teriflunomide : a novel oral treatment for relapsing multiple sclerosis.
Atypical Optic Neuritis.
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience.
Role of vitamin D in acquired immune and autoimmune diseases.
Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.
Similar genetics of adult and pediatric MS: Age is just a number.
Drugs in Development for Relapsing Multiple Sclerosis.
Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
An unusual case of neurobrucellosis presenting as demyelination disorder.
Intrathecal versus Oral Baclofen; a Matched Cohort Study of Spasticity, Pain, Sleep, Fatigue and Quality of Life.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
Immunotherapy using LPS-stimulated Bone Marrow-derived Dendritic Cells to Treat Experimental Autoimmune Encephalomyelitis.
[Multiple sclerosis.]
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Voxel-based cervical spinal cord mapping of diffusion abnormalities in MS-related myelitis.
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity.
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE.
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
Pages
« first
‹ previous
…
334
335
336
337
338
339
340
341
342
…
next ›
last »